108 related articles for article (PubMed ID: 8690823)
1. Effects of dihydropyridine calcium antagonists on albuminuria in patients with diabetes.
Abbott K; Smith A; Bakris GL
J Clin Pharmacol; 1996 Mar; 36(3):274-9. PubMed ID: 8690823
[TBL] [Abstract][Full Text] [Related]
2. Contrasting effects of calcium channel blockade versus converting enzyme inhibition on proteinuria in African Americans with non-insulin-dependent diabetes mellitus and nephropathy.
Guasch A; Parham M; Zayas CF; Campbell O; Nzerue C; Macon E
J Am Soc Nephrol; 1997 May; 8(5):793-8. PubMed ID: 9176849
[TBL] [Abstract][Full Text] [Related]
3. Effects of sodium intake on albumin excretion in patients with diabetic nephropathy treated with long-acting calcium antagonists.
Bakris GL; Smith A
Ann Intern Med; 1996 Aug; 125(3):201-4. PubMed ID: 8686978
[TBL] [Abstract][Full Text] [Related]
4. Long-term renoprotection by perindopril or nifedipine in non-hypertensive patients with Type 2 diabetes and microalbuminuria.
Jerums G; Allen TJ; Campbell DJ; Cooper ME; Gilbert RE; Hammond JJ; O'Brien RC; Raffaele J; Tsalamandris C;
Diabet Med; 2004 Nov; 21(11):1192-9. PubMed ID: 15498085
[TBL] [Abstract][Full Text] [Related]
5. Effects of different ACE inhibitor combinations on albuminuria: results of the GUARD study.
Bakris GL; Toto RD; McCullough PA; Rocha R; Purkayastha D; Davis P;
Kidney Int; 2008 Jun; 73(11):1303-9. PubMed ID: 18354383
[TBL] [Abstract][Full Text] [Related]
6. Moderate salt restriction with or without paricalcitol in type 2 diabetes and losartan-resistant macroalbuminuria (PROCEED): a randomised, double-blind, placebo-controlled, crossover trial.
Parvanova A; Trillini M; Podestà MA; Iliev IP; Ruggiero B; Abbate M; Perna A; Peraro F; Diadei O; Rubis N; Gaspari F; Carrara F; Stucchi N; Belviso A; Bossi AC; Trevisan R; Remuzzi G; de Borst M; Ruggenenti P;
Lancet Diabetes Endocrinol; 2018 Jan; 6(1):27-40. PubMed ID: 29104158
[TBL] [Abstract][Full Text] [Related]
7. Effects of low-dose nifedipine on urinary protein excretion rate in patients with renal disease.
Kloke HJ; Wetzels JF; Koene RA; Huysmans FT
Nephrol Dial Transplant; 1998 Mar; 13(3):646-50. PubMed ID: 9550641
[TBL] [Abstract][Full Text] [Related]
8. The calcium antagonist isradipine in the therapy of hypertension. A double-blind crossover comparison with nifedipine.
Welzel D; Burger KJ
Drugs; 1990; 40 Suppl 2():60-4. PubMed ID: 2150644
[TBL] [Abstract][Full Text] [Related]
9. Effects of an ACE inhibitor/calcium antagonist combination on proteinuria in diabetic nephropathy.
Bakris GL; Weir MR; DeQuattro V; McMahon FG
Kidney Int; 1998 Oct; 54(4):1283-9. PubMed ID: 9767545
[TBL] [Abstract][Full Text] [Related]
10. Metabolic effects of isradipine in non-insulin-dependent diabetes mellitus (NIDDM) hypertensive patients.
Ferrara LA; De Simone G; Iannuzzi R; Gaeta I; D'Orta G; Turco S; Guida L; Marotta T
Cardiovasc Drugs Ther; 1995 Jun; 9(3):459-60. PubMed ID: 8527356
[No Abstract] [Full Text] [Related]
11. Regression of nifedipine-induced gingival hyperplasia following switch to a same class calcium channel blocker, isradipine.
Westbrook P; Bednarczyk EM; Carlson M; Sheehan H; Bissada NF
J Periodontol; 1997 Jul; 68(7):645-50. PubMed ID: 9249636
[TBL] [Abstract][Full Text] [Related]
12. Kidney-protective effects of azelnidipine versus a diuretic in combination with olmesartan in hypertensive patients with diabetes and albuminuria: a randomized study.
Kojima M; Okubo S; Mizubayashi R; Isaka N; Machida H; Okamoto S; Hirota H; Takeuchi M; Kato T; Nakatani K; Mizuno O; Miyagawa K; Makino K; Okura T; Dohi Y; Ito M; Kimura G
Nephrol Dial Transplant; 2013 Jul; 28(7):1802-10. PubMed ID: 23535223
[TBL] [Abstract][Full Text] [Related]
13. Calcium channel blockers versus other antihypertensive therapies on progression of NIDDM associated nephropathy.
Bakris GL; Copley JB; Vicknair N; Sadler R; Leurgans S
Kidney Int; 1996 Nov; 50(5):1641-50. PubMed ID: 8914031
[TBL] [Abstract][Full Text] [Related]
14. [Comparison of treatment effects with an angiotensin converting enzyme inhibitor--lisinopril and a calcium blocker--nifedipine retard on urinary albumin excretion in patients with non-complicated essential hypertension].
Widecka K; Celibała R; Czekalski S
Pol Arch Med Wewn; 1995 Feb; 93(2):135-42. PubMed ID: 7479231
[TBL] [Abstract][Full Text] [Related]
15. Effect of lacidipine, a dihydropyridine calcium antagonist on renal function of hypertensive patients with renal insufficiency.
Bailey RR; Shand BI; Smith AH; Robson RA; Lynn KL
Clin Nephrol; 1997 Oct; 48(4):224-9. PubMed ID: 9352156
[TBL] [Abstract][Full Text] [Related]
16. Effects of isradipine in Type 1 (insulin-dependent) diabetic patients with albuminuria and normal blood pressure.
Nørgaard K; Jensen T; Feldt-Rasmussen B
J Hum Hypertens; 1992 Apr; 6(2):145-50. PubMed ID: 1534581
[TBL] [Abstract][Full Text] [Related]
17. Long-term effects of angiotensin-converting enzyme inhibition and metabolic control in hypertensive type 2 diabetic patients.
Chan JC; Ko GT; Leung DH; Cheung RC; Cheung MY; So WY; Swaminathan R; Nicholls MG; Critchley JA; Cockram CS
Kidney Int; 2000 Feb; 57(2):590-600. PubMed ID: 10652036
[TBL] [Abstract][Full Text] [Related]
18. Equivalent reduction of proteinuria in hypertensives by either nifedipine GITS or enalapril: disparate effects on neurohormones and ambulatory blood pressure and the influence of salt.
DeQuattro V; Lee DP
Cardiology; 1997; 88 Suppl 3():38-42. PubMed ID: 9397292
[TBL] [Abstract][Full Text] [Related]
19. Albuminuria in diabetes mellitus: relation to ambulatory versus office blood pressure and effects of cilazapril.
Waeber B; Weidmann P; Wohler D; Le Bloch Y
Am J Hypertens; 1996 Dec; 9(12 Pt 1):1220-7. PubMed ID: 8972894
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin converting enzyme inhibitors versus calcium antagonists in the treatment of diabetic hypertensive patients.
Ferder L; Daccordi H; Martello M; Panzalis M; Inserra F
Hypertension; 1992 Feb; 19(2 Suppl):II237-42. PubMed ID: 1735586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
